pre|CISION® peptide drug conjugate platform: Audience

Avacta Therapeutics offers the pre|CISION® platform, which focuses on expanding the reach of highly potent cancer therapies. This innovative platform is designed to enhance the effectiveness of targeted cancer treatments.